Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema.
about
Sublethal Photothermal Stimulation with a Micropulse Laser Induces Heat Shock Protein Expression in ARPE-19 Cells.Recent developments in laser treatment of diabetic retinopathyDiabetic macular edema: New promising therapies.Functional outcome of subthreshold versus threshold diode laser photocoagulation in diabetic macular oedema.Diabetic retinopathy (treatment)Long-term therapeutic efficacy of the subthreshold micropulse diode laser photocoagulation for diabetic macular edema.Green or yellow laser treatment for diabetic macular edema: exploratory assessment within the Diabetic Retinopathy Clinical Research NetworkDiabetic macular edema: new trends in management.Pilot randomized trial of a nanopulse retinal laser versus conventional photocoagulation for the treatment of diabetic macular oedema.Subthreshold diode laser micropulse photocoagulation for the treatment of diabetic macular edema.The short-term efficacy of subthreshold Micropulse yellow (577-nm) laser photocoagulation for diabetic macular edema.Corticosteroid use for diabetic macular edema: old fad or new trend?Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review.Pain score of patients undergoing single spot, short pulse laser versus conventional laser for diabetic retinopathy.Diabetic retinopathy: pathogenesis, clinical grading, management and future developments.Pathophysiology and treatment of diabetic retinopathy.Efficacy of subthreshold micropulse laser in the treatment of diabetic macular edema is influenced by pre-treatment central foveal thickness.The management of diabetic macular oedemaEvolving strategies in the management of diabetic retinopathySubthreshold diode-laser micropulse photocoagulation as a primary and secondary line of treatment in management of diabetic macular edemaRandomised clinical trial evaluating best-corrected visual acuity and central macular thickness after 532-nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema.Comparative efficacy of pure yellow (577-nm) and 810-nm subthreshold micropulse laser photocoagulation combined with yellow (561-577-nm) direct photocoagulation for diabetic macular edema.Novel Therapies in Development for Diabetic Macular Edema.Temperature-Controlled Retinal Photocoagulation Reliably Generates Uniform Subvisible, Mild, or Moderate Lesions.Subthreshold Diode Micropulse Laser: A Review.Diabetic macular oedema: pathophysiology, management challenges and treatment resistance.On the relationship between visual acuity and central retinal (macular) thickness after interventions for macular oedema in diabetics: a review.Biological Modulation of Mouse RPE Cells in Response to Subthreshold Diode Micropulse Laser Treatment.Sub-threshold micro-pulse diode laser treatment in diabetic macular edema: A Meta-analysis of randomized controlled trials.Comparison of subthreshold diode laser micropulse therapy versus conventional photocoagulation laser therapy as primary treatment of diabetic macular edema.A Review of Subthreshold Micropulse Laser and Recent Advances in Retinal Laser Technology.A Review of Subthreshold Micropulse Laser for Treatment of Macular DisordersDiabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.Recent developments in retinal lasers and delivery systems.Comprehensive detection, grading, and growth behavior evaluation of subthreshold and low intensity photocoagulation lesions by optical coherence tomographic and infrared image analysis.Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema.Peripapillary nerve fiber layer thickness changes after macular photocoagulation for clinically significant diabetic macular edema.Nondamaging Retinal Laser Therapy: Rationale and Applications to the Macula.The Role of Focal Laser in the Anti-Vascular Endothelial Growth Factor Era.
P2860
Q27315036-3F07DE56-B6DE-4C46-8D14-710722A0E9A4Q28084139-05FF4725-687C-4543-BB2D-70AD7B78806CQ30415630-5815B24C-2630-49EC-9EDC-753C722FE72BQ33568530-D357FB13-92CA-4C36-8D15-0A08B7C0A509Q33910631-65A5B983-9794-44CE-AB3B-9F2E534D8A2EQ33925407-64A298F8-2A67-41BA-994F-924C7FEAEC63Q34018552-72314F52-6830-419A-8095-82A524884B68Q34091784-74DD4C8F-9D85-4E28-A995-86AD398D020EQ34148987-0F92D2D2-EF9F-40B8-B479-A5B023DC5A60Q34190128-374F7515-0FF7-47EB-8712-C5EA680AE11DQ34263219-76A2EE77-6C5A-4966-A08B-D662CA77616EQ34267270-7189A427-6FDE-40D7-A010-B460B1240449Q34269588-AABEDA06-EC62-4D3B-B399-7D079C6A3B4AQ34439672-621D23EC-3470-4DD1-B603-B07944AA1E10Q34498235-85D0F516-C793-42A2-9A3B-991C86E3DD27Q34528134-83B816AE-25A6-40E7-A1AD-6EC515C0E635Q34718520-6F6EC574-DC1E-4C16-8559-969B1B96440CQ34957921-93E419A8-14BB-4C63-870B-6EFD4510F4B5Q35067102-680306E9-F4C2-4132-9DDB-4B9CDF2B935EQ35147159-7908F279-3FA2-4DD4-B3F9-5FCA71484E60Q35196889-20F04A31-074A-4141-AE61-51B32EC8BE06Q35416180-4E13E8CD-97AB-4C0A-ACDB-EAE42ABE6C48Q35751912-AA603E06-E8F7-485F-8B33-8D4A469411E2Q35809887-6FE5730D-D7E7-401E-9446-4E152CE01917Q35950863-35B958D9-15BB-41A8-AB56-1E8299700EE0Q36018006-646EEEFE-7D21-4582-848F-49C594E739DEQ36056409-A5D3EF73-6947-4A74-B933-982D9E966E49Q36063372-DED3C140-B865-4CF1-AA24-6C8C0D1DE762Q36097239-0DDE4F43-774B-4BF5-A523-D34D7B2187E8Q36188116-7F9B6043-8532-4F96-AF8B-E05FF95DBA7FQ36276337-56D88FE1-5906-4725-8B1D-03E51F2A48B8Q36379671-DECE1B05-056F-4D92-9D0A-1B893035BA79Q37477129-C2E07B40-04B1-4921-BCCE-68ECD8D054D4Q38184853-1EBF5F92-BC34-4FED-9D3B-819C7EADE2DEQ40029684-3A71FB62-90A7-4CE0-B309-DDF39D52FF1BQ41250047-3BDF7F94-1473-4642-8D81-6FEB7AE2AD94Q41789955-665954BB-430D-4784-A27E-9ED8F4381188Q46204149-4A362729-E4D2-4524-955E-F4B8C2E2D466Q47099972-8B181E12-0CAD-4079-AECB-F6D3A6DDFDA8
P2860
Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Prospective randomised control ...... icant diabetic macular oedema.
@ast
Prospective randomised control ...... icant diabetic macular oedema.
@en
type
label
Prospective randomised control ...... icant diabetic macular oedema.
@ast
Prospective randomised control ...... icant diabetic macular oedema.
@en
prefLabel
Prospective randomised control ...... icant diabetic macular oedema.
@ast
Prospective randomised control ...... icant diabetic macular oedema.
@en
P2093
P50
P356
P1476
Prospective randomised control ...... ficant diabetic macular oedema
@en
P2093
J F de Abreu
S Sivaprasad
P304
P356
10.1136/BJO.2008.146712
P407
P577
2008-12-03T00:00:00Z